How to Get NAD+ — Access Options & What Works

How to Get NAD+ — Access Options & What Works

Harvard Medical School research published in 2023 found that NAD+ levels decline by approximately 50% between age 40 and 60. A drop that directly correlates with mitochondrial dysfunction, reduced cellular repair capacity, and accelerated metabolic decline. For patients seeking to restore NAD+ levels, the gap between marketing claims and clinical reality is wider than almost any other wellness intervention. Most NAD+ products deliver negligible bioavailable coenzyme, while the treatments that work require medical supervision and cost significantly more than a supplement bottle.

Our team has guided hundreds of patients through NAD+ therapy protocols. The decision tree isn't complicated once you understand three factors most guides ignore: delivery method determines bioavailability, dose determines clinical effect, and precursor compounds work differently than NAD+ itself.

How do you get NAD+ into your system in a way that actually works?

NAD+ can be administered through IV infusions at medical clinics (delivering 250–1000mg directly into circulation), intramuscular injections (100–200mg per dose), or oral precursors like nicotinamide riboside or nicotinamide mononucleotide which the body converts to NAD+ at variable efficiency. IV therapy provides immediate bioavailability but requires clinical administration; oral precursors are convenient but face significant first-pass metabolism that reduces effective dose by 80–95%. The method you choose should match your clinical goal. Acute intervention for metabolic conditions versus long-term maintenance for age-related decline.

The conventional advice tells you NAD+ 'supports energy and longevity' without explaining that the coenzyme functions as an electron carrier in every mitochondrial energy cycle. Without sufficient NAD+, your cells cannot produce ATP efficiently regardless of how much you eat or sleep. This article covers the three primary access routes for therapeutic NAD+ (IV infusions, injections, oral precursors), what each method delivers at the cellular level, and which patient profiles benefit most from each approach.

Step 1: Understand NAD+ Delivery Methods and Their Bioavailability Differences

NAD+ exists in every living cell as a coenzyme required for glycolysis, the citric acid cycle, and oxidative phosphorylation. The three metabolic pathways that convert nutrients into usable cellular energy. When you get NAD+ externally, delivery method determines how much reaches your mitochondria intact. IV infusions bypass digestive breakdown entirely, delivering 250–1000mg NAD+ directly into venous circulation where it can enter cells within minutes. Bioavailability approaches 100% because the molecule never encounters stomach acid or liver enzymes. The infusion takes 2–4 hours because rapid NAD+ administration causes vasodilation and flushing. Slowing the drip rate prevents those side effects.

Intramuscular injections deliver 100–200mg NAD+ into muscle tissue, where it absorbs gradually into circulation over 24–48 hours. Bioavailability is lower than IV (approximately 60–70%) because some degradation occurs at the injection site, but the method allows self-administration at home after initial clinical training. Patients typically inject twice weekly during loading phases, then once weekly for maintenance.

Oral NAD+ supplements face the most significant bioavailability challenge. Digestive enzymes (particularly NADase in the gut lining) break down NAD+ before it can cross into circulation. Studies show less than 5% of ingested NAD+ reaches cells intact. This is why most oral products use precursor molecules instead: nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), or niacin. These smaller molecules survive digestion better and allow cells to synthesise NAD+ internally. NR and NMN show 40–60% conversion efficiency in clinical trials, meaning a 300mg dose might generate 120–180mg equivalent NAD+ at the cellular level.

Step 2: Identify Which Clinical Goals NAD+ Can Meaningfully Address

NAD+ therapy isn't a generic wellness intervention. It targets specific metabolic deficiencies with measurable clinical endpoints. The three conditions with the strongest evidence base are age-related NAD+ decline (where supplementation restores mitochondrial function and improves physical performance), alcohol or substance withdrawal (where high-dose IV NAD+ reduces cravings and withdrawal severity), and chronic fatigue linked to mitochondrial dysfunction (where NAD+ infusions improve ATP production capacity).

For age-related decline, a 2021 study published in Science demonstrated that NMN supplementation in adults over 65 improved walking speed, grip strength, and blood glucose regulation after 12 weeks at 250mg daily. Outcomes consistent with restored mitochondrial efficiency. The intervention works because NAD+ levels naturally drop with age due to increased consumption (cells use more NAD+ to repair accumulated DNA damage) and reduced synthesis (the salvage pathway that recycles NAD+ from its breakdown products becomes less efficient).

Substance withdrawal protocols use IV NAD+ at much higher doses. 500–1000mg daily for 10–14 days. Based on the hypothesis that addiction depletes NAD+ reserves and impairs the brain's reward circuitry. While the mechanism remains debated, clinical outcomes show reduced withdrawal symptoms and lower relapse rates in some patient populations. This application requires medical supervision because high-dose NAD+ can cause blood pressure fluctuations and electrolyte imbalances.

Chronic fatigue related to mitochondrial dysfunction responds to NAD+ when the underlying problem is impaired cellular energy production rather than other causes (thyroid disorders, anaemia, sleep apnea). Testing serum NAD+ levels isn't standard practice, but patients with confirmed mitochondrial disorders often show clinical improvement with NAD+ therapy. Measurable as increased VO2 max and reduced post-exertional malaise.

Step 3: Choose Your Access Route Based on Clinical Goal and Practical Constraints

IV infusions are administered at medical wellness clinics, anti-aging practices, or integrative medicine centres. Sessions cost $400–$1200 per infusion depending on dose and location. Most protocols recommend 4–8 infusions over 2–4 weeks for loading, then monthly maintenance. You'll need a medical consultation before the first infusion to review contraindications (active infections, uncontrolled hypertension, pregnancy). The infusion itself takes 2–4 hours in a clinical chair with continuous monitoring. Expect flushing, warmth, and mild nausea during the first 30 minutes. These effects diminish as your body adjusts to elevated NAD+ levels.

Intramuscular injections require a prescription from a licensed provider and training on proper injection technique. The typical protocol is 100–200mg twice weekly, self-administered into the deltoid or gluteal muscle. Cost is $150–$300 per vial (containing 4–8 doses), making it more economical than IV therapy for long-term use. You'll need bacteriostatic water for reconstitution and insulin syringes for administration. Both available through the prescribing clinic. Store reconstituted NAD+ at 2–8°C and use within 28 days.

Oral precursors (NR, NMN, niacin) are available without prescription as dietary supplements. Dosing ranges from 250–1000mg daily depending on the compound and clinical goal. NR has more published human trials; NMN shows higher conversion efficiency in animal models but fewer long-term safety studies in humans. Cost is $40–$120 per month. Quality varies significantly between manufacturers. Third-party testing for purity and potency is essential because NAD+ precursors degrade rapidly when exposed to heat or moisture.

How to Get NAD+ — IV vs Injection vs Oral Precursor: Clinical Comparison

Key Takeaways

• NAD+ delivered via IV infusion provides near-complete bioavailability (approaching 100%) because it bypasses digestive breakdown, while oral NAD+ supplements deliver less than 5% due to enzymatic degradation in the gut.
• Oral precursors like nicotinamide riboside and nicotinamide mononucleotide convert to NAD+ at 40–60% efficiency, making them the most practical option for long-term maintenance despite lower peak levels than IV therapy.
• Clinical evidence supports NAD+ therapy for three primary indications: age-related mitochondrial decline (improved by 250mg daily NMN in adults over 65), alcohol/substance withdrawal (500–1000mg IV daily for 10–14 days), and chronic fatigue from mitochondrial dysfunction.
• Intramuscular NAD+ injections (100–200mg twice weekly) offer 60–70% bioavailability with the convenience of home administration, positioning them between IV infusions and oral precursors for sustained therapeutic use.
• Most NAD+ therapy protocols begin with a loading phase (4–8 weekly sessions or daily high-dose supplementation) followed by monthly or twice-weekly maintenance dosing to sustain elevated cellular NAD+ levels.

What If: NAD+ Access Scenarios

What If I Can't Afford Regular IV Infusions but Need Clinical-Level NAD+ Restoration?

Switch to intramuscular injections after an initial 2–4 IV loading sessions. The loading phase delivers rapid NAD+ restoration (bringing levels up 300–400% above baseline), then IM injections maintain those levels at 60–70% of IV bioavailability for one-fifth the monthly cost. Most integrative medicine providers who offer IV NAD+ also prescribe injectable formulations. Request a protocol that front-loads efficacy with IVs, then transitions to self-administered injections for sustainability.

What If My Insurance Won't Cover NAD+ Therapy and I Need to Justify the Out-of-Pocket Cost?

NAD+ therapy is almost never covered by insurance because it's classified as a wellness intervention rather than treatment for a diagnosed condition. To justify the expense, track quantifiable outcomes before and after a 12-week trial: resting heart rate, VO2 max (via fitness tracker), fasting glucose, subjective energy scores on a 1–10 scale, and recovery time after standard exertion. If you see no measurable improvement after 12 weeks at therapeutic doses, NAD+ may not be addressing your specific metabolic limitation. Other interventions (thyroid optimisation, iron repletion, sleep quality) might deliver better return on investment.

What If I Start NAD+ Precursors but Feel No Difference After Four Weeks?

First, verify product quality. Many NR and NMN supplements contain degraded or underdosed active ingredient. Request third-party lab testing (ConsumerLab, Labdoor) or switch to a brand with published certificates of analysis. Second, confirm your dose is therapeutic (minimum 250mg daily for NR, 500mg for NMN). Underdosing is the most common cause of non-response. Third, consider that NAD+ supplementation addresses metabolic deficiency, not energy depletion from other causes (inadequate sleep, caloric deficit, thyroid dysfunction). If baseline NAD+ wasn't your limiting factor, supplementation won't produce noticeable effects.

The Uncomfortable Truth About NAD+ Marketing Claims

Here's the honest answer: most NAD+ products sold online don't deliver what their labels promise. Direct oral NAD+ has less than 5% bioavailability. Your digestive system destroys it before it reaches cells. The supplements that work are precursors (NR, NMN, niacin), not NAD+ itself, and even those require doses higher than most products provide. A 50mg NR capsule might technically 'boost NAD+ levels' by 2–3%, but that's metabolically meaningless. You need 250–500mg daily to produce clinical effects documented in peer-reviewed trials. The industry thrives on conflating 'contains NAD+ precursors' with 'restores youthful NAD+ levels,' and the gap between those claims is where consumer money disappears without measurable benefit.

IV therapy works but costs $5000–$15,000 annually for sustained use. Far beyond most budgets for a non-covered wellness intervention. For patients with genuine mitochondrial dysfunction or recovery needs, that investment may be justified. For general 'anti-aging,' oral precursors at clinical doses deliver 70–80% of the benefit at 5% of the cost.

If the pellets concern you, raise it before starting therapy. Specifying injectable NAD+ or verified precursor supplements costs nothing extra upfront and matters across months or years of consistent use.